Tackling unmet healthcare needs, with a focus on safety and tolerability in patients.
Joined June 2020
- Tweets13
- Following53
- Followers143
- Likes29
HDAX Therapeutics retweeted
Immensely proud of @HDAXtx co-founders and Gunning Group alumni @NabanitaNawar and Pimyupa Manaswiyoungkul for being named among the 2023 @Forbes 30 Under 30 Toronto!
#ForbesUnder30Local #Forbes30under30 #gunningalumni
forbes.com/sites/forbesunder…
We're excited to announce that HDAX has been chosen to participate in #MassBioDrive fall 2022 cohort!
We are pleased to announce the six emerging startups chosen to participate in the #MassBioDrive Fall 2022 Cohort: AdductNE, @HDAXtx, @HybridexBio, Jenthera Therapeutics Inc., Orion, and pacDNA massbio.org/innovation-servi…
Super excited to be selected as an ALPHA startup at @CollisionHQ! Come check us out at Booth A1102 tomorrow (Tuesday, June 21st 2022) to learn more about how @HDAXtx is designing a targeted therapeutic platform for unmet healthcare needs. #Collision2022
We had a fantastic chat with @donovanbailey at #UofTEntWeek hosted by @UofTStartup and excited to be 1st prize winners of the 2022 #UofTStartupPrize pitch competition
HDAX Therapeutics retweeted
Nabanita Nawar, co-founder of U of T startup @HDAXtx from the @GunningLabUofT pitching at the #UofTStartupPrize pitch competition. #UofTEntWeek
Tune in to show your support at the U of T Entrepreneurship Startup Prize pitch competition on March 7th at 2 pm. Visit uoft.me/entweek to register. #UofTStartupPrize
We have been selected for the Emerging Companies Forum at the 18th Annual BIOTECanada Investor Summit. Thank you @BIOTECanada and @adMare_Bio for the exciting opportunity!
We're excited to welcome @ABOzymes, Cura Therapeutics, Damona pharma & @HDAXtx, the companies selected to present at our Emerging Co.'s Forum at @BIOTECanada's upcoming Investor Summit. adMare is all about building companies, and these 4 are ones to watch!admarebio.com
Amazing pitches and excited to be the winners of the 2021 Therapeutics Focus Award and 2nd Place at #BioTech2021
The #BioTEC2021 pitch competition was a huge success! Thank you to the pitch competition teams, panel of VC judges, industry mentors, and sponsors!
* 1st: Epiloid
* 2nd: @HDAXtx
* 3rd: Vope Medical
* Therapeutics focus award: @HDAXtx
* People’s choice: @vope_ai
Thrilled to be one of the winners of @H2i_UofT 's Pitch Perfect competition 😀
This Post is from an account that no longer exists. Learn more
HDAX Therapeutics retweeted
Congratulations to Nabanita Nawar @HDAXtx for winning 2021 Best Presentation at the invitational @SweetPharmaDay event!
#HDAC
Thank you @SweetPharmaDay for amazing sessions today, and honored to have been named 2021 best presentation at this invitation-only life sciences event!
Thank you @SweetPharmaDay for amazing sessions today, and honored to have been named 2021 best presentation at this invitation-only life sciences event!
This Post is from a suspended account. Learn more
HDAX Therapeutics retweeted
Very excited that our #HDAX Therapeutics team is a part of the @Lab2MarketCA (#L2M)Toronto Summer 2021 Cohort! Wishing them all the best as they set off on their entrepreneurial journey towards research commercialization!
@MitacsCanada #HDAXTx #startup #innovation
Meet L2M Toronto's Summer 2021 Cohort!
Delivered by @RyersonU, 23 talented teams from 8 universities will be embarking on their entrepreneurial journey. Read about the diverse cohort here: buff.ly/3tWW5pQ
Thank you to the Government of Canada + Mitacs for the support.
Thank you @MbD_UofT and @H2i_UofT for supporting our work at Building a Biotech Venture Pitch Competition, mbd.utoronto.ca/news/hdax-th…
At #MedicinebyDesign’s Building a Biotech Venture Pitch Competition, HDAX Therapeutics (@Patrick_Gunning lab) was chosen to receive $25,000 in funding for their #regenmed concept, a small molecule therapy that could have an impact on Alzheimer's disease ➡️mbd.utoronto.ca/news/hdax-th…
